SNCB

synuclein beta, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 5:176620081-176630556

Links

ENSG00000074317NCBI:6620OMIM:602569HGNC:11140Uniprot:Q16143AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Lewy body dementia (Moderate), mode of inheritance: Unknown
  • Lewy body dementia (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Dementia with Lewy bodiesADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic15365127

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SNCB gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SNCB gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
6
clinvar
6
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
7
clinvar
8
Total 0 0 6 2 7

Variants in SNCB

This is a list of pathogenic ClinVar variants found in the SNCB region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-176620760-G-A Benign (May 15, 2021)1222753
5-176620840-C-T not specified Uncertain significance (Aug 26, 2022)2309219
5-176620954-C-T Benign (May 17, 2021)1178596
5-176621205-C-T SNCB-related disorder Likely benign (Jul 10, 2019)3050307
5-176621218-G-T Lewy body dementia • SNCB-related disorder Conflicting classifications of pathogenicity (Dec 30, 2023)7026
5-176626335-GGT-G Benign (May 15, 2021)1282871
5-176626335-GGTGT-G Benign (May 15, 2021)1253251
5-176626411-G-A Lewy body dementia Uncertain significance (-)3024092
5-176626449-G-C not specified Uncertain significance (Sep 29, 2022)2314526
5-176626472-C-T Lewy body dementia Pathogenic (Sep 14, 2004)7025
5-176626621-G-A Benign (May 15, 2021)1267656
5-176626644-C-G Benign (May 15, 2021)1257127
5-176629528-A-G not specified • Lewy body dementia Benign (Jul 15, 2021)1174817
5-176629547-G-A not specified Likely benign (Oct 27, 2023)2637515
5-176629555-T-C Lewy body dementia Uncertain significance (Dec 02, 2020)1333743
5-176629618-C-G Lewy body dementia Uncertain significance (Jul 01, 2020)2436214
5-176629648-C-T not specified Uncertain significance (Sep 23, 2023)3166954
5-176629805-C-T not specified Benign (May 15, 2021)1181147

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SNCBprotein_codingprotein_codingENST00000310112 510446
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.06810.877125738091257470.0000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9525072.90.6860.00000332853
Missense in Polyphen1219.0750.62911214
Synonymous-0.2793129.11.070.00000143262
Loss of Function1.6337.940.3783.93e-792

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001490.000148
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001790.0000176
Middle Eastern0.000.00
South Asian0.00009830.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Non-amyloid component of senile plaques found in Alzheimer disease. Could act as a regulator of SNCA aggregation process. Protects neurons from staurosporine and 6-hydroxy dopamine (6OHDA)-stimulated caspase activation in a p53/TP53- dependent manner. Contributes to restore the SNCA anti-apoptotic function abolished by 6OHDA. Not found in the Lewy bodies associated with Parkinson disease.;
Pathway
MTF1 activates gene expression;MTF1 activates gene expression;Response to metal ions;Cellular responses to external stimuli (Consensus)

Recessive Scores

pRec
0.221

Intolerance Scores

loftool
0.375
rvis_EVS
-0.05
rvis_percentile_EVS
49.39

Haploinsufficiency Scores

pHI
0.489
hipred
Y
hipred_score
0.589
ghis
0.654

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.637

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sncb
Phenotype
normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
sncb
Affected structure
larval locomotory behavior
Phenotype tag
abnormal
Phenotype quality
decreased occurrence

Gene ontology

Biological process
chemical synaptic transmission;response to metal ion;dopamine metabolic process;negative regulation of catalytic activity;negative regulation of neuron apoptotic process;synaptic vesicle endocytosis;synapse organization
Cellular component
cytosol;inclusion body;presynapse
Molecular function
phospholipase inhibitor activity;calcium ion binding;transition metal ion binding;cuprous ion binding